We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc
ALPN

Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

38 hedge funds and large institutions have $22.3M invested in Alpine Immune Sciences Inc in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

24% less funds holding

Funds holding: 50 → 38 (-12)

55% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 22

78% less capital invested

Capital invested by funds: $100M → $22.3M (-$77.9M)

Holders
38
Holders Change
-12
Holders Change %
-24%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
7
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
+$1.22M
2
AFM
Anson Funds Management
Texas
+$938K
3
BI
BVF Inc
California
+$771K
4
Millennium Management
Millennium Management
New York
+$200K
5
FO
FT Options
Illinois
+$174K

Top Sellers

Rank Fund Capital Flow
1
Axa
Axa
France
-$5.3M
2
Franklin Resources
Franklin Resources
California
-$3.98M
3
Jennison Associates
Jennison Associates
New York
-$2.67M
4
EAM
EverPoint Asset Management
Connecticut
-$1.79M
5
SFM
Sphera Funds Management
Israel
-$1.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$8.36M – – –
BI
2
BVF Inc
California
$4.18M +$771K +38,701 +9%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$2.85M -$1.25M -62,808 -16%
TM
4
Tiger Management
New York
$1.46M – – –
KCM
5
Kingdon Capital Management
New York
$1.17M -$109K -5,447 -4%
RSCM
6
Rock Springs Capital Management
Maryland
$1.09M – – –
PAM
7
Panagora Asset Management
Massachusetts
$550K +$1.22M +61,407 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$450K -$353K -17,695 -26%
AFM
9
Anson Funds Management
Texas
$422K +$938K +47,072 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$285K +$877 +44 +0.1%
PA
11
Perceptive Advisors
New York
$274K – – –
BCM
12
Bridgeway Capital Management
Texas
$168K – – –
BIT
13
BlackRock Institutional Trust
California
$127K – – –
Goldman Sachs
14
Goldman Sachs
New York
$94K -$174K -8,723 -45%
SM
15
Sabby Management
Florida
$90K -$1.13M -56,912 -85%
Millennium Management
16
Millennium Management
New York
$90K +$200K +10,021 New
FO
17
FT Options
Illinois
$78K +$174K +8,750 New
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$68K +$151K +7,576 New
RI
19
RTW Investments
New York
$67K – – –
BFA
20
BlackRock Fund Advisors
California
$57K +$3.89K +195 +3%
SIM
21
Spark Investment Management
New York
$55K +$34.4K +1,725 +39%
MFS
22
MSI Financial Services
Massachusetts
$45K – – –
AIM
23
Acrospire Investment Management
Illinois
$40K +$88.1K +4,422 New
VKH
24
Virtu KCG Holdings
New York
$33K +$12.9K +649 +22%
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$33K +$72.7K +3,646 New
1
2 3

ALPN Hedge Fund Activity: Q4 2016 in Review

38 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q4 2016, worth a combined $22.3M — down 78% from $100M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ALPN and 10 opened new positions — a net loss of 12 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was Panagora Asset Management, opening a new position worth an estimated $1.22M. The largest seller was Axa, exiting entirely with an estimated $5.3M sold.

  • 38 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q4 2016, down from 50 in Q3 2016.
  • Funds reported $22.3M of Alpine Immune Sciences Inc stock for Q4 2016, down 78% quarter-over-quarter.
  • 10 funds opened new Alpine Immune Sciences Inc positions in Q4 2016 and 22 closed out, a net change of -12 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q4 2016 was Panagora Asset Management, an estimated $1.22M added.
  • The largest Alpine Immune Sciences Inc seller in Q4 2016 was Axa, an estimated $5.3M sold.

Based on aggregated 13F filings for Q4 2016.